Evaluation of the effects of testosteronundecanoat and hypercaloric nutrition in addition to rehabilitative training for patients with severe and very severe COPD
Conditions
Interventions
Trade Name: Nebido 1000 mg/4ml Ampullen
Pharmaceutical Form: Injection*
Sponsors
Prof.Dr.Hartmut ZWICK
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Male participants COPD (GOLD III and IV) Age 45 - 80 yrs BMI =65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Prostatic hyperplasia Prostatic carcinoma Pathological values of PSA, blood-sugar and blood-count Hypercaloric nutrition within 6 months before study Androgenic therapy or anabolic steroids within 6 months before study Unstable condition of an other sickness Unstable COPD Chronic pain Immobility Pathologic. psychiatric and psychologic condition Alcohol and drug abusus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Enhancement of quality of life and capacity of patients with COPD (GOLD III and IV) and BMI <20. Evaluation of influence of dispension of serumtestosteron and hypercaloric nutrition on muscular strength and aerobic capacity;Secondary Objective: ;Primary end point(s): Change of the strength of the musculus quadriceps femoris Change of maximal inspiratory pressure Change of maximal aerobic capacity Change of health related quality of life Change of fat free body mass | — |
Countries
Austria
Outcome results
None listed